1. MARKETS
  2. SECTOR : SOFTWARE & SERVICES
  3. INDUSTRY : PACKAGED SOFTWARE
  4. BIOTRICITY INC
Biotricity Inc XNAS: BTCY

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Biotricity Inc is on 18 Jul 2025 for the purpose of Biotricity Inc Annual Report for 2025 See details


Insider Trading disclosures for Biotricity Inc

The latest disclosure was made by Waqaas Al-Siddiq in Biotricity Inc where a trade of 1,000,000 Option (right to purchase) done was reported to US exchanges on March 12, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Waqaas Al-Siddiq Director, President, CEO and Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2023 1,000,000 4,899,984 - - Option (right to purchase)
Waqaas Al-Siddiq Director, President, CEO and Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2023 350,000 3,899,984 - - Option (right to purchase)
Waqaas Al-Siddiq Director, President, CEO and Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2023 350,000 3,549,984 - - Option (right to purchase)
David A. Rosa Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Mar 2023 75,930 474,683 - - Option (right to buy)
Norman Murray Betts Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2021 54,348 375,598 - 0 Common Stock
David Rosa Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Nov 2021 27,174 152,174 - 0 Common Stock
David Rosa Director Sale of securities on an exchange or to another person at price $ 3.08 per share. 07 Oct 2021 17,228 137,799 - 3.1 53,119 Common Stock
David Rosa Director Sale of securities on an exchange or to another person at price $ 3.20 per share. 07 Oct 2021 9,481 128,318 - 3.2 30,334 Common Stock
David Rosa Director Sale of securities on an exchange or to another person at price $ 3.05 per share. 07 Oct 2021 3,318 125,000 - 3.1 10,120 Common Stock
David Rosa Director Sale of securities on an exchange or to another person at price $ 3.43 per share. 15 Sep 2021 34,977 155,027 - 3.4 119,915 Common Stock
David Rosa Director Sale of securities on an exchange or to another person at price $ 3.27 per share. 15 Sep 2021 6,246 190,004 - 3.3 20,421 Common Stock
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 550,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 218,785 1,328,488 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 118,282 1,109,703 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 53,827 991,421 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 37,594 937,594 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 900,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 800,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 750,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 700,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 650,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 600,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 500,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 450,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 400,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 350,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 300,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 250,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 200,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 150,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 100,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 50,000 - - Warrants
John Ayanoglou Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Oct 2017 50,000 850,000 - - Warrants
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters